Page last updated: 2024-10-30

leflunomide and Moniliasis, Oral

leflunomide has been researched along with Moniliasis, Oral in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vaish, AK1
Tripathi, AK1
Gupta, LK1
Jain, N1
Agarwal, A1
Verma, SK1

Other Studies

1 other study available for leflunomide and Moniliasis, Oral

ArticleYear
An unusual case of DRESS syndrome due to leflunomide.
    BMJ case reports, 2011, Sep-04, Volume: 2011

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Candidiasis, Oral; Diagnosis, Differential; Drug Eru

2011